Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Holding VRTX?
Track your performance easily

Vertex Pharmaceuticals (VRTX) Financial Statements

5,600 Followers

Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.025; its P/E ratio is -232.56; Vertex Pharmaceuticals is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $4.08. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.65B$ 2.69B$ 2.52B$ 2.48B$ 2.49B
Gross Profit$ 2.27B$ 2.35B$ 2.15B$ 2.16B$ 2.18B
EBIT$ -3.38B$ 1.29B$ 1.17B$ 1.19B$ 1.17B
EBITDA$ -3.33B$ 1.34B$ 1.23B-$ 1.21B
Net Income Common Stockholders$ -3.59B$ 1.10B$ 968.80M$ 1.04B$ 915.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.80B$ 10.17B$ 11.22B$ 11.93B$ 11.24B
Total Assets$ 20.13B$ 23.92B$ 22.73B$ 21.73B$ 20.35B
Total Debt$ 933.40M$ 721.30M$ 724.70M$ 744.70M$ 767.60M
Net Debt$ -4.86B$ -9.45B$ -10.49B$ -11.18B$ -10.47B
Total Liabilities$ 5.36B$ 5.37B$ 5.15B$ 5.21B$ 4.88B
Stockholders Equity$ 14.77B$ 18.55B$ 17.58B$ 16.51B$ 15.47B
Cash Flow-
Free Cash Flow$ -3.82B$ 1.24B$ 118.50M-$ 1.08B
Operating Cash Flow$ -3.75B$ 1.31B$ 234.60M$ 1.27B$ 1.14B
Investing Cash Flow$ -463.70M$ -2.14B$ -886.50M$ -115.20M$ -304.50M
Financing Cash Flow$ -358.60M$ -357.50M$ -119.80M$ -165.00M$ 17.30M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis